Dixon T S Woon
Overview
Explore the profile of Dixon T S Woon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu J, Sandhu K, Woon D, Perera M, Lawrentschuk N
Semin Nucl Med
. 2025 Feb;
PMID: 39893058
This review aims to provide an up-to-date overview of the utility of artificial intelligence (AI) in evaluating prostate-specific membrane antigen (PSMA) positron emission tomography (PET) scans for prostate cancer (PCa)....
2.
Liu J, OBrien J, Nandakishor K, Sathianathen N, Teh J, Manning T, et al.
Cancers (Basel)
. 2024 Dec;
16(23).
PMID: 39682158
: Penile cancer is aggressive and rapidly progressive. Early recognition is paramount for overall survival. However, many men delay presentation due to a lack of awareness and social stigma. This...
3.
Sii S, Papa N, Yiu T, Tempo J, Qu L, Perera M, et al.
BJU Int
. 2024 Nov;
PMID: 39607059
Objective: To investigate the relationship between the prostate-specific antigen (PSA) free-to-total ratio (FTR) and International Society of Urological Pathology Grade Group ≥2, clinically significant prostate cancer (csPCa) in men with...
4.
Dong L, Lajkosz K, Sanchez-Salas R, Kuk C, Xu W, Tiwari R, et al.
J Natl Compr Canc Netw
. 2024 Nov;
22(10).
PMID: 39546889
Background: Historically, Asia had a lower prostate cancer (PCa) incidence and mortality compared with Western countries, but the gap is narrowing. Paradoxically, Asians have been reported to present with more...
5.
Liu J, Zhang H, Woon D, Perera M, Lawrentschuk N
Cancers (Basel)
. 2024 Nov;
16(21).
PMID: 39518036
: Biochemical recurrence (BCR) after radical prostatectomy (RP) is a significant predictor of distal metastases and mortality in prostate cancer (PCa) patients. This systematic review aims to evaluate the accuracy...
6.
Liu J, Hiwase M, Woon D, Thomas B, Tran B, Lawrentschuk N
BJU Int
. 2024 Oct;
135(2):214-221.
PMID: 39448381
Objective: To conduct a systematic review of the current literature to determine the current role of primary retroperitoneal lymph node dissection (RPLND) in stage II testicular seminoma and its associated...
7.
Liu J, Cundy T, Woon D, Desai N, Palaniswami M, Lawrentschuk N
BJU Int
. 2024 Jul;
134(5):714-722.
PMID: 39003625
Objectives: To assess artificial intelligence (AI) ability to evaluate intraprostatic prostate cancer (PCa) on prostate-specific membrane antigen positron emission tomography (PSMA PET) scans prior to active treatment (radiotherapy or prostatectomy)....
8.
Liu J, Cundy T, Woon D, Lawrentschuk N
Cancers (Basel)
. 2024 Feb;
16(3).
PMID: 38339239
Early detection of metastatic prostate cancer (mPCa) is crucial. Whilst the prostate-specific membrane antigen (PSMA) PET scan has high diagnostic accuracy, it suffers from inter-reader variability, and the time-consuming reporting...
9.
Liu J, Santucci J, Woon D, Catterwell R, Perera M, Murphy D, et al.
Life (Basel)
. 2024 Jan;
14(1).
PMID: 38255691
Active surveillance remains a treatment option for low- to intermediate-risk prostate cancer (PCa) patients. Prostate-specific membrane antigen positron emission tomography and computed tomography (PSMA PET/CT) has emerged as a useful...
10.
Qaoud Y, Bettoli P, Sanmamed-Salgado N, Herrera-Caceres J, Berjaoui M, Lajkosz K, et al.
Eur Urol Open Sci
. 2021 Aug;
21:1-4.
PMID: 34337460
No abstract available.